Trials / Suspended

SuspendedNCT04838223

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Summary

This study is designed to measure how common nerve abnormalities are within a group of patients who feel discomfort within their eyes.

Type	Name	Description
OTHER	Hyperosmolar Response	A single drop of hypertonic sodium chloride solution at room temperature will be instilled in each eye and change in pain/other symptoms after up to 90 seconds of application (to account for any initial irritation symptoms) will be observed.
OTHER	Proparacaine Challenge Test	A single drop of Proparacaine hydrochloride ophthalmic solution, (Alcaine®, 0.5%) will be used on each eye respectively and any change in pain/other symptoms will be noted after 90 seconds (to account for initial discomfort from the preservative in Proparacaine solution).
OTHER	Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Optional; only for Contact Lens Wearers	The CLDEQ-8 is a validated eight-item scaled questionnaire developed to reflect the overall opinion of soft contact lenses.
OTHER	Ocular Pain Assessment Survey (OPAS)	Twenty seven-item quantitative questionnaire designed to provide an assessment of the symptoms and quality of life effect of ocular pain \[18\]. The 27 items of the OPAS questionnaire are graded on a scale of 0 to 10, or 10 to 100, where 0 indicates none and 10 or 100 indicate maximum.
OTHER	Visual Analogue Questionnaire	Symptoms of ocular comfort and dryness will be graded for each eye on a scale of 0-10, where 0=extremely uncomfortable, extremely dry and 10=excellent comfort, no dryness. An average rating will be provided for the morning, afternoon and evening.

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04838223. Inclusion in this directory is not an endorsement.